Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to 0.49.

  • Core Scientific's Equity Ratio rose 3791.02% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 3791.02%. This contributed to the annual value of 0.51 for FY2024, which is 3879.95% up from last year.
  • As of Q3 2025, Core Scientific's Equity Ratio stood at 0.49, which was up 3791.02% from 0.54 recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Equity Ratio ranged from a high of 0.55 in Q4 2021 and a low of 1.44 during Q2 2024
  • Moreover, its 5-year median value for Equity Ratio was 0.49 (2025), whereas its average is 0.31.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 64169.62% in 2022, then plummeted by 124114.35% in 2023.
  • Core Scientific's Equity Ratio (Quarter) stood at 0.55 in 2021, then plummeted by 192.16% to 0.51 in 2022, then tumbled by 65.39% to 0.84 in 2023, then skyrocketed by 38.8% to 0.51 in 2024, then increased by 4.23% to 0.49 in 2025.
  • Its Equity Ratio was 0.49 in Q3 2025, compared to 0.54 in Q2 2025 and 0.11 in Q1 2025.